| Literature DB >> 31068833 |
Lucrezia Zuccarelli1,2, Letizia Galasso3, Rachel Turner4, Emily J B Coffey5, Loredana Bessone2, Giacomo Strapazzon2,4.
Abstract
Background: Successful long-duration missions outside low-Earth orbit will depend on technical and physiological challenges under abnormal environmental conditions. Caves, characterized by absence of light, confinement, three-dimensional human movement and long-duration isolation, are identifiably one of the earliest examples of scientific enquiry into space analogs. However, little is known about the holistic human physiological response during cave exploration or prolonged habitation.Entities:
Keywords: cave; circadian rhythms; extreme environments; human physiology; space analog; spaceflight
Year: 2019 PMID: 31068833 PMCID: PMC6491700 DOI: 10.3389/fphys.2019.00442
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Characteristics of short exposure studies.
| Study design | Longitudinal | Longitudinal | Cross-sectional | Case report | Cross-sectional | Case report | Longitudinal | Longitudinal | Longitudinal | Randomized, double blind, cross-over | Longitudinal | Longitudinal | Longitudinal |
| Sample size(n) [males] | 17 [10] | 40 [24] | 23 [15] | na | 19 [14] | 1 [0] | 5 [5] | 5 [5] | 5 [5] | 10 [10] | 7 [6] | 6 [0] | 13 [12] |
| Place (depth/distance) | Cave and lab (−100 m/10.6 ± 2.2 | Cave | Cave and lab (na/na) | Cave (na/±10 m) | Lab and simulated cave tent | Cave | Cave | Cave | Cave | Cave | Cave | Cave | Caves |
| Environmental | Cave: 12–15 | 14–15 | na | 47 | 22 | na | 2 | 2 | 2 | na | na | na | na |
| Humidity (%) | Lab: 50 Cave: 95–100 | 95–100 | na | 100 | 76 lab | na | High humidity | High humidity | na | na | na | na | na |
| Light exposure (head lamps) | na | Yes | Yes | Yes | na | na | na | na | Yes | Yes | na | Yes | na |
| Time period in cave environment(h) | 9.4 ± 1.2 | 8–10 | ~6 | 0.15–1 | <1 | ~23 | ~20 | ~20 | 18 | 12 | ~22 | up to 6 | 30 days with cave activity |
| Exercise | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Interval measurement | Continuous monitoring during cave progression | BL (time 0), continuous monitoring and time end | One evaluation in lab and one evaluation in cave | BL (time 0), time end | BL (time 0), continuous monitoring and time end | BL (time 0), continuous monitoring | Four days before, BL (time 0), time 12, 24, 48 h | BL (time 0), time 12, 24, 48 h | BL (time 0), 1.7, 5, 18 and 24 h | BL (time 0), various time points in cave, and time end | BL (time 0), various time points in cave | BL (time 0), continuous monitoring | BL (time 0) and time end |
| Parameters | AT, EE,HR, | BMI, EE, hydration evaluation, nutritional habits, %FFM, %FM, | BVA, contrast sensitivity, intraocular pressure, near visual activity, ocular alignment refractive error, VA | BF, BP, ECG glycemia, HR, SaO2, Tcore, urine analysis, visual analog rating scale, Wassler's test | BP, glycemia, HR, SaO2, symptoms, lab | ECG, HRV, tachogram | Cortisol, FT3, FT4, GH, TSH, %ΔPV | Hb, MCV, RBC, Trectal, %ΔPV | CK, CK-MB, Hp, LDH, leucocytes platelets | BP, CK, creatinine, ECG, electrolytes (Na+,K+, Mg++), HCT, HR, plasma LDH, pH and ketones in urine, urine density | Glycemia, food diary | BMI, FEV1, FVC,HR, Livi index, MVV, skin folds, Tiffeneau-Pinelli index,V'O2, %FFM, %FM | Skin folds, TBW, %FFM, %FM, |
| Other parameters | na | ECG, height, weight, BP, | na | BMI, symptoms, weight | ECG | na | Height, weight, %FM | Height, weight, %FM | Height, weight, skin folds, BMI, %FM | Height, weight, BMI | Height, weight, BMI | Height | Height, weight |
Mean ± Standard deviation.
Range.
AT, anaerobic threshold; BF, breath frequency; BL, baseline; BMI, Body Mass Index; BP, blood pressure; BVA, binocular visual acuity; CK, creatine kinase; CK-MB, MB isoenzyme of CK; ECG, electrocardiogram; EE, energy expenditure; FEV1, forced expiratory volume in the first second; FT3, free triiodothyronine; FT4, free thyroxine; FVC, forced expiratory volume; GH, serum growth hormone; Hb, hemoglobin; HCT, hematocrit; Hp, haptoglobin; HR, heart rate; HRV, heart rate variability; K+, plasma potassium; la.
Characteristics of prolonged exposure studies.
| Study design | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal | Longitudinal |
| Sample size ( | 1 [0] | 1 [0] | 1 [0] | 1 [0] | 1 [0] | 3 [3] | 1 [1] | 2 [1] | 1 [1] | 7 [0] | 2 [1] | 1 [1] | 2 [2] | 2 [1] | 1 [0] | 1 [1] | 1 [1] | 2 [2] |
| Subject's age(years) | 28 | 32 | 32 | 27 | 27 | 23; 23; 28 | 28 | M: 35F: 25 | 24 | 20–35 | M: 35 F: 25 | 25 | na | M: 35F: 25 | 26 | na | na | 20;43 |
| Place (depth) | Lab in cave!!!!!—special habitat like Lunar Base (na) | Cave | Cave | Lab in cave (−9.1 5 m) | Cave | Different caves (−70 m) | Cave | Two different caves with tent, tables, chairs, instruments(−80; −7 0 m) | Cave | Cave with tents, tables, chairs, instruments (−100 m) | Two different caves with tents, beds, chairs (−80; −70 m) | Cave with tent (−70 m) | Cave | Two different caves with tents, beds, chairs | Cave | Cave (−130 m) | Cave | Cave with habitat, tables, beds, chairs (~−45 m) |
| Environmental temperature(°C) | na | na | na | na | 22 ± 0 | 6 | na | 6 ± 2 | na | 11 ± 0.1 | 6 ± 2 | Cave: 6–7 | na | 6 ± 2 | na | na | 7 | 12 |
| Humidity(%) | na | na | na | na | 90 | 100 | na | 100 | na | 98 | 100 | 100 | na | 100 | na | na | ~100 | na |
| Light exposure (artificial light) | yes | yes | Yes | Yes, constant | na | Yes, constant illuminated | na | Yes, lamps 50 lux | na | Yes, light by helmet5–10 | Yes, as desired | Yes | na | Yes, lamps 50 lux | Yes, light 50 lux | Yes, pleasure ~ 13.5 lm | Yes, candles or forehead lamp | Yes, lanterns |
| Isolation (way of communication | Yes | Yes | Yes | Yes (computer) | Yes (computer) | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes!!!!!i (telephone and yes clock) | Yes |
| Time periodin cave environment(days) | 267 | 103 | 103 | 131 | 97 | 174;150;150 | 127 | Male: 125 | 174 | 14 | Male: 125 | 174 | 58; 174 | Male: 125 | 88 | 62 | 105 | 32 |
| Exercise | na | na | na | na | na | Yes | na | yes | na | na | na | yes | na | na | na | na | Yes | na |
| Interval measurement | 24 days before, continuous (20 min), 69 days after | Before, during and after | Before, during and after | Before, during and after | Various time points during isolation | 5 days before, during and 5 days after isolation | During and after isolation | Before, during and after 1 month of isolation | During and after isolation | Before, during and after isolation | Before, during and 1 month after isolation | Various time points during isolation | Various time points during isolation | Before, during and after isolation | Before, during and after isolation | Various time points during isolation | One day before, during and after isolation | Various time points during isolation |
| Parameters | BP cycle, HR cycle | Caffeine metabolite ratio, creatinine excretion rate, Turinary, urinary volume, 17-OHCS | Caffeine metabolite ratio, estimation period time sleep-wake cycle, urinary system cycle, Turinary, water excretion rate, 17-OHCS | Hb, HCT, IFN-γ, leucocytes, lymphocytes, MCH, MCHC, MCV, NK, platelet, RBC, WBC | BP cycle, HR cycle, Taxillary Tsublingual | EEG, EMG, EOG | Chloride cycle, creatine, KU, NaU, phosphate, sleep-wake cycle, plasma steroid | Estimation period time, HR cycle, KU, Trectal, urinaryvolume, 17-OHCS | Estimation of spontaneous time and reaction time, sleep-wake cycle | Sleep-wake cycle | Sleep-wake cycle, Trectal, 17-OHCS | Sleep-wake cycle, spontaneous activity,Trectal | Estimation period time, simple reaction time, sleep-wake cycle | Blood values, HR cycle, oftalgic parameters, sleep-wake cycle, Trectal, urinary volume | Menstrual cycle, Trectal | Estimation period time, HR cycle, sleep-wake cycle | Creatinine, electrolytes (chloride, NaU, KU), urinary pH cycle, sleep-wake cycle | Sleep-wake cycle, Tcore |
| Other | Cosmic ray | Cosmic ray, menstrual cycle | Defecation, drinking eating | Bone density, BP cycle, menstrual cycle, sleep-wake cycle | na | Cardiac cycle, sleep-wake cycle, Trectal | na | Grip strength, menstrual cycle, sleep-wake cycle, visual evaluation, weight | Meals cycle | na | na | EEG, sleep-wake cycle | na | Dynamometric force tests, K+, Na+, weight | na | na | Steroid estimation | na |
Mean ± Standard Deviation.
Range.
BP, blood pressure; EEG, electroencephalogram; EMG, electromyography; EOG, electrooculography; HCT, hematocrit; Hb, hemoglobin; HR, heart rate; IFN-γ, interferon gamma; K+, plasma potassium; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; na, not available; Na+, plasma sodium; NK, natural killer cells; RBC, red blood cells; Tcore, core body temperature; Turinary, urinary temperature; Trectal, rectal temperature; KU, urinary potassium; NaU, urinary sodium; WBC, white blood cells; 17-OHCS, 17-hydroxycorticosteroid.
Figure 1Search and screening strategy based on PRISMA guidelines.
Short exposure studies main results.
| V°O2 | Peak in lab 32.4 ± 6.4 | Peak in lab 34.6 ± 3.4 | na | na | na | na | na | na | na | na | na | 22–46 | na |
| EE | na | na | na | na | na | na | na | na | na | na | na | na | |
| EE | In lab at exhaustion: 674.3 ± 197.7 | na | na | na | na | na | na | na | na | na | na | na | |
| FFM | na | na | na | na | na | na | na | na | na | na | na | 71.80–81.56 | ↓ |
| FM | na | = | na | na | na | na | 20.4 ± 0.8 | 19.1–21.4 | 19.1–21.4 | na | na | 18.44–28.20 | ↓ |
| SaO2!!!!! | na | na | na | na | 90–95 | na | na | na | na | na | na | na | na |
| Tcore | na | na | na | ↑ | na | na | na | ↑ | na | na | na | na | na |
| BP | na | na | na | ↑ | = | na | na | na | na | ↑ | na | na | na |
| HR | In lab: 166 ± 8.5 | na | na | ↑ | ↑ | na | na | na | na | ↑ | na | ↑ | na |
| LF/HF | na | na | na | na | na | ↑ | na | na | Na | na | na | na | na |
| CK | na | na | na | na | na | na | na | na | ↑ | ↑ | na | na | na |
| LDH | na | na | na | na | na | na | na | na | ↑ | ↑ | na | na | na |
| Hp | na | na | na | na | na | na | na | na | ↓ | na | na | na | na |
| Lab | na | na | na | na | Normal air: 4.22 ± 1.39 | na | na | na | na | na | na | na | na |
| GH | na | na | na | na | na | na | ↑ | na | na | na | na | na | na |
| Cortisol | na | na | na | na | na | na | ↓ | na | na | na | na | na | na |
| FT3 | na | na | na | na | na | na | = | na | na | na | na | na | na |
| FT4 | na | na | na | na | na | na | ↑ | na | na | na | na | na | na |
| TSH | na | na | na | na | na | na | = | na | na | na | na | na | na |
| Glycemia | na | na | na | na | Normal air: 85.5 ± 13.57 | na | na | na | na | na | ~80 | na | na |
| RBC | na | na | na | na | na | na | na | ↑ | na | na | na | na | na |
| Hb | na | na | na | na | na | na | na | ↑ | na | na | na | na | na |
| MCV | na | na | na | na | na | na | na | ↓ | na | na | na | na | na |
| ΔPV | na | na | na | na | na | na | ↓ | ↓ | na | na | na | na | na |
| Lymphocytes | na | na | na | na | na | na | na | na | ↓ | na | na | na | na |
| Leucocytes | na | na | na | na | na | na | na | na | ↑ | na | na | na | na |
| Neutrophils | na | na | na | na | na | na | na | na | ↑ | na | na | na | na |
| Monocytes | na | na | na | na | na | na | na | na | ↑ | na | na | na | na |
| Platelets | na | na | na | na | na | na | na | na | ↑ | na | na | na | na |
| Visual performance | na | na | BVA = contrast sensitivity ↑ | na | na | na | na | na | na | na | na | na | na |
| Symptoms | na | na | No visual pathologies related to cave environment | Dyspnea, heat stroke, weakness (device failure) | Headache, heat sensation dizziness, ocular pruritus, trembling hands | na | na | na | na | Better recovery from efforts | na | na | na |
Mean ± Standard Deviation
Range; ↑, increased; ↓, decreased; =, stable
BP, blood pressure; BVA, binocular visual acuity; CK, creatine kinase; EE, energy expenditure; FFM, fat free mass; FM, fat mass; FT3, free triiodothyronine; FT4, free thyroxine; GH, growth hormone; Hb, hemoglobin; Hp, haptoglobin; HR, heart rate; la.
Prolonged exposure studies main results.
| Sleep-wake cycle | na | na | ↑ | ↑ | na | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | na | ↑ | ↑ | Imposed 28 h |
| Amplitude | na | na | ↑ | ↑ | na | ↑ | ↑ | na | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | na | ↑ | ↑ | na |
| Thermoregulatory cycle | na | ↑ | ↑ | na | ↑ | ↑ (only for one subject) | na | ↑ | na | na | ↑ | = (circadian 24 h) | na | = (circadian 24 h) | ↑ | na | na | = (~circadian 24 h) |
| Amplitude (cycle period) | na | ↑ | ↑ | na | ↑ | na | na | ↑ | na | na | ↑ | ↑ | na | ↑ | ↑ | na | na | na |
| Cardiorespiratory cycle | ↑ | na | na | na | ↑ | na | na | na | na | na | na | na | na | na | na | na | na | na |
| BP cycle | ↑ | na | na | 7 day circaseptan rhythm | ↑ | na | na | na | na | na | na | na | na | na | na | na | na | na |
| HR cycle | ↑ | na | na | na | ↑ | na | na | na | na | na | na | na | na | Circadian 24 h(↑ period) | na | ↑ | na | na |
| Renal cycle | na | ↑ | ↑ | na | na | na | ↑ | na | na | na | na | na | na | na | na | na | ↑ | na |
| Water excretion rate | na | ↑ | ↑ | na | na | na | na | na | na | na | na | na | na | na | na | na | na | na |
| NaU cycle | na | na | na | na | na | na | = | na | na | na | na | na | na | na | na | na | Irregular | na |
| KU cycle | na | na | na | na | na | na | = | Irregular | na | na | na | na | na | na | na | na | ↑ | na |
| 17-OHCS cycle | na | ↑ | ↑ | na | na | na | na | ↑ | na | na | ↑ | na | na | na | na | na | na | na |
| Menstrual cycle | na | ↑ | na | Halted in the first month | na | na | na | na | na | na | na | na | na | na | ↓ | na | na | na |
| RBC(1012.l−1) | na | na | na | ↓ = | na | na | na | na | na | na | na | na | na | = | na | na | na | na |
| Hb(g.l−1) | na | na | na | ↓ = | na | na | na | na | na | na | na | na | na | = | na | na | na | na |
| HCT | na | na | na | ↓↑ | na | na | na | na | na | na | na | na | na | na | na | na | na | na |
| Leucocytes!!!!!(103μL) | na | na | na | ↓ | na | na | na | na | na | na | na | na | na | = | na | na | na | na |
| Lymphocytes | na | na | na | ↑ | na | na | na | na | na | na | na | na | na | na | na | na | na | na |
| Platelets | na | na | na | ↓↑ | na | na | na | na | na | na | na | na | na | na | na | na | na | na |
| Visual performance | na | na | na | na | na | na | na | Transient modification | na | na | na | na | na | = apart from | na | na | na | na |
| Bone density | na | na | na | ↓ | na | na | na | na | na | na | na | na | na | na | na | na | na | na |
| Simple reaction time | na | na | na | na | na | na | na | na | ↑↓ | na | na | na | ↑ | na | na | na | na | na |
| Estimation period time | na | na | ↑ | na | na | na | na | ↓ | ↑ | na | na | na | = ↓↑ | na | na | ↑ | na | na |
| Symptoms | na | na | na | na | na | na | na | na | na | na | na | na | na | Diarrhea | na | na | na | na |
Mean ± Standard Deviation.
Range; ↑, increased; ↓, decreased; = , stable.
BP, blood pressure; Hb, hemoglobin; HCT, hematocrit; HR, heart rate; KU, urinary potassium; NaU, urinary sodium; RBC, red blood cells; sub., subjects; 17-OHCS, 17-hydroxycorticosteroid.